Absci Corp (ABSI)
5.08
+0.10
(+2.01%)
USD |
NASDAQ |
May 03, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Absci Total Assets (Quarterly): 217.30M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 217.30M |
| September 30, 2023 | 236.34M |
| June 30, 2023 | 254.15M |
| March 31, 2023 | 295.81M |
| December 31, 2022 | 321.01M |
| September 30, 2022 | 339.39M |
| June 30, 2022 | 366.32M |
| Date | Value |
|---|---|
| March 31, 2022 | 395.46M |
| December 31, 2021 | 426.20M |
| September 30, 2021 | 449.12M |
| June 30, 2021 | 257.07M |
| March 31, 2021 | 222.83M |
| December 31, 2020 | 88.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
88.57M
Minimum
Dec 2020
449.12M
Maximum
Sep 2021
297.66M
Average
295.81M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 92.98B |
| Creative Medical Technology Holdings Inc | 10.72M |
| CytomX Therapeutics Inc | 201.79M |
| HOOKIPA Pharma Inc | 161.34M |
| Recursion Pharmaceuticals Inc | 653.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 41.12M |
| Shareholders Equity (Quarterly) | 176.18M |
| Debt to Equity Ratio | 0.0449 |
| Current Ratio | 4.079 |
| Net Debt Paydown Yield | 0.05% |